{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "glycosylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5353365",
      "entity_text" : "CSC",
      "entity_type" : "simple_chemical"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0591" ],
      "CellLine" : [ "cellosaurus:CVCL_0062" ],
      "Cellular_component" : [ "go:GO:0070062" ],
      "Organ" : [ "uberon:UBERON:0005910" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0002327" ]
    }
  },
  "verbose_text" : "Terao et al. showed that fucosylation, a common modification in pancreatic cancer CSC like cells from lectin microarray analysis, could serve as a novel biomarker to determine anticancer drug resistance.127 A lectin microarray performed by Sakaue et al. revealed that the CSC marker CD133 in ascites derived exosomes from patients with unresectable pancreatic cancer is commonly glycosylated by sialic acids.",
  "reading_complete" : "2020-08-04T14:09:36Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:03:40Z",
  "trigger" : "glycosylated",
  "evidence" : [ "CSC marker CD133 in ascites-derived exosomes from patients with unresectable pancreatic cancer is commonly glycosylated" ],
  "pmc_id" : "7050261",
  "score" : 0
}